Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:614-615 (23 September), doi:10.1136/bmj.333.7569.614
Should it be available over the counter?
| The first 150 words of the full text of this article appear below. |
Naloxone saves lives. Timely injection of the opiate antagonist naloxone rapidly reverses the respiratory suppression of heroin overdose,1 2 a major cause of death in young people.3 4 Recent regulatory amendments increase significantly the extent to which naloxone can now be used to prevent opiate overdose deaths. In June 2005, in the Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order,5 the United Kingdom added naloxone to the limited list of medicines that may be given by injection "by anyone for the purpose of saving life in an emergency" (alongside emergency adrenaline, glucagons, and snake antivenin). An emergency dose of naloxone may now be given to prevent death from heroin overdose without specific medical instruction. In August 2005, New York state passed legislation (bills A.7162-A (Dinowitz) and S.4869-A (Hannon)) establishing that physicians may lawfully prescribe naloxone explicitly for potential future opiate overdose, including the situation where it may be administered to someone
John Strang, director
National Addiction Centre (Institute of Psychiatry/The Maudsley), London SE5 8AF
(j.strang@iop.kcl.ac.uk)
Michael Kelleher, consultant psychiatrist in the addictions, David Best, honorary senior lecturer in the addictions, Soraya Mayet, specialist registrar in the addictions, Victoria Manning, research worker in the addictions
National Addiction Centre (Institute of Psychiatry/The Maudsley), London SE5 8AF
Read all Rapid Responses